Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLRB Cellectar Biosciences Inc.

盘前交易 12-19 04:08:17 EST

0.2490

-0.0134

-5.11%

最高0.2701	最低0.2450	成交量437.49万
今开0.2600	昨收0.2624	日振幅9.57%
总市值1,028万	流通市值768.85万	总股本4,127万
成交额110.70万	换手率14.17%	流通股本3,088万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLRB","market":"US","secType":"STK","nameCN":"Cellectar Biosciences Inc.","latestPrice":0.249,"timestamp":1734555600000,"preClose":0.2624,"halted":0,"volume":4374887,"delay":0,"floatShares":30877600,"shares":41269830,"eps":-1.920768,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.0134,"latestTime":"12-19 04:08:17 EST","open":0.26,"high":0.2701,"low":0.245,"amount":1106956.13316596,"amplitude":0.095655,"askPrice":0.3885,"askSize":100,"bidPrice":0.1077,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.920768,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734618600000},"adr":0,"adjPreClose":0.249,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":0.2496,"preClose":0.249,"latestTime":"19:58 EST","volume":39841,"amount":9888.0837,"timestamp":1734569934556},"volumeRatio":0.3280165145243842,"impliedVol":1.1017,"impliedVolPercentile":0.5714},"requestUrl":"/m/hq/s/CLRB","defaultTab":"news","newsList":[{"id":"2492135237","title":"Cellectar Biosciences, Inc.盘中异动 临近午盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492135237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492135237?lang=zh_cn&edition=full","pubTime":"2024-12-19 00:33","pubTimestamp":1734539606,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日00时33分，Cellectar Biosciences, Inc.股票出现异动，股价快速跳水5.11%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Polyrizon Ltd.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Cognition Therapeutics, Inc.涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为2729.98%、555.74%、309.36%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为227.62%、118.27%、88.12%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121900332695ea56f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121900332695ea56f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","BK4007","CLRB","BK4139"],"gpt_icon":0},{"id":"2492932611","title":"Cellectar Biosciences, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492932611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492932611?lang=zh_cn&edition=full","pubTime":"2024-12-17 00:28","pubTimestamp":1734366480,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日00时28分，Cellectar Biosciences, Inc.股票出现异动，股价大幅下跌5.00%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Tonix Pharmaceuticals Holding Corp.、Sagimet Biosciences Inc. - Series A、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Tonix Pharmaceuticals Holding Corp.、Aptevo Therapeutics Inc.、Genprex, Inc.较为活跃，换手率分别为261.09%、44.76%、36.95%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Tonix Pharmaceuticals Holding Corp.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为65.83%、65.28%、61.43%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217002800984c7368&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217002800984c7368&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2490381773","title":"Cellectar Biosciences, Inc.盘中异动 股价大跌6.62%报0.285美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490381773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490381773?lang=zh_cn&edition=full","pubTime":"2024-12-12 23:29","pubTimestamp":1734017390,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日23时29分，Cellectar Biosciences, Inc.股票出现异动，股价急速下挫6.62%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Tc Biopharm  Plc C/Wts 10/02/2028 、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3204.63%、828.00%、71.37%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Palisade Bio, Inc.，振幅分别为75.86%、73.01%、63.57%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212232951984b990a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212232951984b990a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2490374862","title":"BUZZ--美国股票走势-Candel Therapeutics、Broadcom、Reddit","url":"https://stock-news.laohu8.com/highlight/detail?id=2490374862","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490374862?lang=zh_cn&edition=full","pubTime":"2024-12-12 00:18","pubTimestamp":1733933898,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      12月11日 - 华尔街主要股指周三上涨，此前的通胀数据维持了对美联储本月晚些时候降息的押注不变。美东时间10:30，道琼斯工业平均指数  上涨0.03%，报44,259.91点。标普500指数  上涨0.66%，报6,074.64点；纳斯达克综合指数  上涨1.26%，报19,935.91点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLNC","PLAY","QTTB","AVGO","CADL","IBRX","CLRB","LENZ","UDOW","CGON","M","PSQ","PDCO","RLAY",".DJI","AVGOP","PLD","FIGS","LOAR","MDLZ","MNKD",".SPX","ACI","GTLS","ALK","OMC","AMZN","EGP","AZO","DNUT","CCB","DJX","GEV","RDDT","LUV","QLD","SFIX",".IXIC","GM","SDOW","SIRI","MNQmain","DOG","RCKT","QID","NQmain","TQQQ","ANVS","XOM"],"gpt_icon":1},{"id":"2490865786","title":"BUZZ-Cellectar 生物科学公司因可能出售先导药物而创下历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2490865786","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490865786?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:14","pubTimestamp":1733930042,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (更新)    12月11日 - ** 药物开发商Cellectar Biosciences的  股价下跌约 71% ，创下 37美分的历史新低 ** 周二，CLRB 表示可能将 (link) 其实验性 抗癌药物 出售给一家更大的公司或与之合作。** 该决定是在与美国 FDA 就该药物  的 审批要求进行讨论之后做出的。** 该公司表示 将裁员 60%，以将其运营跑道延长至 2025 年第三季度。** 截至2023年12月31日，CLRB共有20名员工--美国证券交易委员会文件** 包括盘中走势在内，该股今年已下跌86.3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2490850527","title":"BUZZ--美国股票走势-埃克森美孚、Mondelez International、梅西百货","url":"https://stock-news.laohu8.com/highlight/detail?id=2490850527","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490850527?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:11","pubTimestamp":1733926289,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nL4T3NC12G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GM","LU2602419157.SGD","LU1150488218.USD","SIRI","FLNC","SFIX","LUV","FIGS","LU0170899867.USD","MDLZ","RLAY","LU1430597077.USD","BK4559","XOM","SG9999015341.SGD","RCKT","EGP","LU1481011911.USD","LU1929549753.HKD","DNUT","LU0070302665.USD","RJF","QTTB","LU1732799900.SGD","BK4077","PDCO","LU0738911758.USD","LU0795875086.SGD","GEV","ALK","PLD","IBRX","CGON","LU0011850046.USD","OMC","ANVS","LU0612318385.USD","LU2249611893.SGD","M","PLAY","CLRB","LU2505996509.AUD","MNKD","LU0130103400.USD","SG9999014567.USD","LU0345770308.USD","CADL","LU1066053197.SGD","LU0320765489.SGD"],"gpt_icon":1},{"id":"2490524855","title":"BUZZ--美国股票走势-通用汽车、GE Vernova、亚马逊","url":"https://stock-news.laohu8.com/highlight/detail?id=2490524855","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490524855?lang=zh_cn&edition=full","pubTime":"2024-12-11 20:10","pubTimestamp":1733919014,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d039160368f49bf807e51f5d9290e21b","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nL4T3NC0TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLAY","LU2111349929.HKD","LU0823421333.USD","IE000YTNTUN2.SGD","SFIX","IE000KEQY171.SGD","LU0672654240.SGD","LU0417517546.SGD","LU0772969993.USD","LU1509826696.USD","IE00B4YYXB79.USD","LU2125154778.USD","OMC","DNUT","BK4551","CGON","LUV","SG9999015945.SGD","RLAY","IBRX","ALK","FLNC","LU1084165304.USD","BK4139","BK4539","AMZN","LU2065171311.SGD","LU2242650005.HKD","LU1988902786.USD","IE00B775H168.HKD","IE00BFSS7M15.SGD","LU1633808545.USD","IE00BJJMRX11.SGD","GM","BK4182","LU0320765059.SGD","LU2361044949.HKD","BK4535","CLRB","LU0724617625.USD","LU2362540622.SGD","LU0642271901.SGD","SG9999015986.USD","LU0256863902.USD","IE00B1BXHZ80.USD","LU1093756168.USD","LU0683600562.USD","LU1064131342.USD","LU1852331112.SGD","GEV"],"gpt_icon":1},{"id":"2490198830","title":"BUZZ-Cellectar生物科学公司因可能出售抗癌药物而暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2490198830","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490198830?lang=zh_cn&edition=full","pubTime":"2024-12-11 19:27","pubTimestamp":1733916431,"startTime":"0","endTime":"0","summary":"12月11日 -  ** 药物开发商Cellectar Biosciences的CLRB.O股价盘前下跌44.3%至71美分 ** 周二，CLRB表示，它可能会把 ，把它的试验性 抗癌药物 卖给一家更大的公司，或者与它合作。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nL4S3NC0RE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2490010121","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490010121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490010121?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:58","pubTimestamp":1733846293,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时58分，Cellectar Biosciences, Inc.股票出现波动，股价大幅下跌5.19%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.43%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、Chimerix, Inc.较为活跃，换手率分别为1939.31%、450.18%、143.38%，振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Jupiter Neurosciences, Inc.，振幅分别为154.91%、131.78%、121.49%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023581395e8b2b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023581395e8b2b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2489496074","title":"Cellectar Biosciences, Inc.盘中异动 快速下挫5.10%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489496074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489496074?lang=zh_cn&edition=full","pubTime":"2024-12-06 02:27","pubTimestamp":1733423267,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日02时27分，Cellectar Biosciences, Inc.股票出现异动，股价大幅跳水5.10%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Protara Therapeutics, Inc.、Molecular Templates, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Protara Therapeutics, Inc.较为活跃，换手率分别为3541.64%、2331.06%、491.84%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Molecular Templates, Inc.、Protara Therapeutics, Inc.，振幅分别为136.00%、124.83%、106.21%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206022747a1d706b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206022747a1d706b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2488924972","title":"Cellectar Biosciences, Inc.盘中异动 下午盘股价大跌5.26%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488924972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488924972?lang=zh_cn&edition=full","pubTime":"2024-12-04 02:42","pubTimestamp":1733251378,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日02时42分，Cellectar Biosciences, Inc.股票出现异动，股价急速下挫5.26%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Janux Therapeutics, Inc.、Jupiter Neurosciences Inc涨幅较大，Quoin Pharmaceuticals Ltd、Nls Pharmaceutics Ltd.、Purple Biotech Ltd较为活跃，换手率分别为168.77%、148.10%、145.15%，振幅较大的相关个股有Jupiter Neurosciences Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为134.75%、69.23%、59.76%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204024258a26a04da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204024258a26a04da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2485892788","title":"Cellectar Biosciences, Inc.2024财年第三财季实现净利润-14.66百万美元，同比减少6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485892788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485892788?lang=zh_cn&edition=full","pubTime":"2024-11-24 00:00","pubTimestamp":1732377628,"startTime":"0","endTime":"0","summary":"11月24日，Cellectar Biosciences, Inc.公布财报，公告显示公司2024财年第三财季净利润为-14.66百万美元，同比减少6.77%；其中营业收入为0.00美元，每股基本收益为-0.37美元。从资产负债表来看，Cellectar Biosciences, Inc.总负债20.75百万美元，其中短期债务80821.00美元，资产负债比为1.80，流动比率为1.77。机构评级：截至2024年11月24日，当前有3家机构对Cellectar Biosciences, Inc.目标价做出预测，其中目标均价为13.33美元，其中最低目标价为7.00美元，最高目标价为21.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000053a250458b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000053a250458b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB"],"gpt_icon":0},{"id":"2485497604","title":"Cellectar Biosciences, Inc.盘中异动 早盘大幅下挫5.13%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485497604?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:39","pubTimestamp":1732199943,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时39分，Cellectar Biosciences, Inc.股票出现异动，股价大幅下挫5.13%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Conduit Pharmaceuticals Inc.、Biodexa Pharmaceuticals Plc、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为253.71%、57.45%、44.45%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.00%、66.75%、39.02%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223903a24b78bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223903a24b78bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2484282982","title":"Cellectar 生物科学公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2484282982","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484282982?lang=zh_cn&edition=full","pubTime":"2024-11-19 06:02","pubTimestamp":1731967346,"startTime":"0","endTime":"0","summary":"Cellectar 生物科学公司公布截至 9 月 30 日的季度业绩 - 收益摘要Cellectar Biosciences Inc CLRB.OQ报告，截至9月30日的季度调整后每股亏损40美分，高于去年同期的每股-83美分。四位分析师对该季度的平均预期是每股亏损 37 美分。Cellectar Biosciences Inc 报告的季度每股收益为亏损 40 美分。该公司当季亏损 1466 万美元。Cellectar Biosciences Inc 的股价本季度下跌了 13.1%，今年迄今为止下跌了 32.9%。华尔街对 Cellectar Biosciences Inc 的 12 个月目标价中位数为 13.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nL4T3MP1J3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2484688609","title":"Cellectar Biosciences, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484688609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484688609?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:40","pubTimestamp":1731951623,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时40分，Cellectar Biosciences, Inc.股票出现波动，股价大幅下跌5.11%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Hcw Biologics Inc.、冠科美博、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Hcw Biologics Inc.、冠科美博、Tharimmune, Inc.较为活跃，换手率分别为1106.86%、674.02%、565.76%，振幅较大的相关个股有Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为563.48%、129.51%、91.09%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119014023abccfd4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119014023abccfd4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2483379322","title":"Cellectar Biosciences Inc   预计每股亏损37美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2483379322","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483379322?lang=zh_cn&edition=full","pubTime":"2024-11-15 21:54","pubTimestamp":1731678850,"startTime":"0","endTime":"0","summary":"   * Cellectar Biosciences Inc    将于11月18日公布截至2024年9月30日的财报，预计该公司的季度收入将保持不变。*    * LSEG 的分析师平均预计 Cellectar Biosciences Inc 每股亏损 37 美分。* 华尔街对 Cellectar Biosciences Inc 的 12 个月目标价中位数为 13.50 美元，高于其最新收盘价 2.01 美元。11月15日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cellectar Biosciences Inc   预计每股亏损37美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB"],"gpt_icon":0},{"id":"2483723332","title":"Cellectar Biosciences, Inc.盘中异动 快速跳水5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483723332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483723332?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:53","pubTimestamp":1731617628,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时53分，Cellectar Biosciences, Inc.股票出现波动，股价快速下挫5.21%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.13%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃，换手率分别为4952.18%、3493.33%、403.47%，振幅较大的相关个股有Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为249.67%、218.18%、188.46%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045348a2388f82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045348a2388f82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2479288056","title":"Cellectar Biosciences Inc    预计每股亏损 34 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479288056","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479288056?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:46","pubTimestamp":1730209562,"startTime":"0","endTime":"0","summary":"   * Cellectar Biosciences Inc    预计在10月31日发布业绩报告时，季度营收将不会有变化(预计)，截至2024年6月30日。*    * LSEG分析师对Cellectar Biosciences Inc的平均预期是每股亏损34美分。* 华尔街对 Cellectar Biosciences Inc 的 12 个月目标价中位数为 13.50 美元，高于其最新收盘价 2.05 美元。10月29日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Cellectar Biosciences Inc    预计每股亏损 34 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB"],"gpt_icon":0},{"id":"2474820391","title":"Cellectar Biosciences, Inc.盘中异动 下午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474820391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474820391?lang=zh_cn&edition=full","pubTime":"2024-10-10 03:07","pubTimestamp":1728500850,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日03时07分，Cellectar Biosciences, Inc.股票出现波动，股价大幅跳水5.08%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Nutriband Inc C/Wts 、Apollomics Inc C/Wts 01/04/2028 、Inhibikase Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为726.64%、573.06%、250.04%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Inhibikase Therapeutics, Inc.，振幅分别为108.00%、73.66%、64.70%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101003073198e3b862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101003073198e3b862&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","CLRB","BK4139"],"gpt_icon":0},{"id":"2473487705","title":"Cellectar Biosciences, Inc.盘中异动 大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473487705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473487705?lang=zh_cn&edition=full","pubTime":"2024-10-08 03:04","pubTimestamp":1728327885,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日03时04分，Cellectar Biosciences, Inc.股票出现异动，股价急速跳水5.00%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Scholar Rock Holding Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Celularity Inc C/Wts 16/07/2026 涨幅较大，Aditxt, Inc.、Tc Biopharm  Plc、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1663.82%、94.85%、60.66%，振幅较大的相关个股有Scholar Rock Holding Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Lakeshore Biopharma Co., Ltd，振幅分别为107.82%、39.46%、38.72%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008030445a1deb4cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008030445a1deb4cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectar.com","stockEarnings":[{"period":"1week","weight":-0.1841},{"period":"1month","weight":-0.8593},{"period":"3month","weight":-0.882},{"period":"6month","weight":-0.9129},{"period":"1year","weight":-0.9042},{"period":"ytd","weight":-0.9101}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cellectar Biosciences, Inc.以前名为Novelos Therapeutics, Inc.于1996年6月成立于特拉华州。2014年2月11日，公司更名为现在的名字。该公司是一家后期临床生物制药公司，专注于癌症治疗药物的发现、开发和商业化。该公司的核心目标是利用专有的磷脂醚药物偶联（PDC）递送平台，开发专门针对癌细胞的PDC，并通过更少的脱靶效应提供更高的疗效和更好的安全性。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.027916},{"month":2,"riseRate":0.6,"avgChangeRate":0.012926},{"month":3,"riseRate":0.5,"avgChangeRate":-0.02847},{"month":4,"riseRate":0.2,"avgChangeRate":-0.095326},{"month":5,"riseRate":0.3,"avgChangeRate":0.04729},{"month":6,"riseRate":0.4,"avgChangeRate":-0.071836},{"month":7,"riseRate":0.3,"avgChangeRate":-0.074001},{"month":8,"riseRate":0.4,"avgChangeRate":-0.015388},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.040633},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.138405},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.073945},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.05541}],"exchange":"NASDAQ","name":"Cellectar Biosciences Inc.","nameEN":"Cellectar Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cellectar Biosciences Inc.(CLRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cellectar Biosciences Inc.,CLRB,Cellectar Biosciences Inc.股票,Cellectar Biosciences Inc.股票老虎,Cellectar Biosciences Inc.股票老虎国际,Cellectar Biosciences Inc.行情,Cellectar Biosciences Inc.股票行情,Cellectar Biosciences Inc.股价,Cellectar Biosciences Inc.股市,Cellectar Biosciences Inc.股票价格,Cellectar Biosciences Inc.股票交易,Cellectar Biosciences Inc.股票购买,Cellectar Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cellectar Biosciences Inc.(CLRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况